Long-acting antiretroviral therapy for hiv treatment: implementation, interest, and preferences for future options
Rebecca Fisk-Hoffman, MPH, successfully defended her dissertation this week at the Clinical and Translational Research Building. Rebecca also recently had an article published entitled, “Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida.”
